In 1998 we published a perspective review describing how drug-induced neuroadaptations might serve towards understanding drug craving. We proposed experimental perspectives to help discern data relevant to long-lasting brain changes, and to distinguish dopamine-related changes that were largely pharmacological from glutamatergic changes that were based on drug-environment associations. These perspectives are embedded in drug abuse research, and the last 18 years has witnessed marked development in understanding addiction-associated corticostriatal glutamate plasticity. Here we propose three new perspectives on how the field might approach integrating and using the emerging data on glutamatergic adaptations. (1) Consider adaptations produced in kind across drug classes as most useful towards understanding shared characteristics of addiction, such as relapse.
Introduction
In the 1998 article we proposed a critical role for glutamate transmission in cocaine addiction, and summarized the relatively scant data supporting this view. In this brief update, we are pleased to report that substantial progress has been made in testing and supporting this hypothesis. At that time, we were concerned that the field of addiction was becoming confused with a variety of seemingly contradictory data generated due to high variability of experimental protocols. We proposed two criteria to help organize the literature and energize future studies. The first criterion was to recognize that there were transient adaptations that could be identified within minutes to days after the last drug administration that were being conflated with enduring adaptations measured after weeks of withdrawal. Thus, to understand the long-lasting disorder of drug addiction it was best to focus on the enduring changes measureable after longer withdrawal periods. We reasoned that while short-lived adaptations are likely important for establishing addiction, the actual disorder is enduring, as should be the corresponding neurobiological underpinnings.
The second criterion was derived from the fact that at that time most data had been generated using noncontingent cocaine injection and focused on the pharmacological actions of the drug. In contrast, addiction is a disorder that is derived from a combination of drug pharmacology and learned associations made between the drug experience and the environment. Moreover, we proposed that studying only the pharmacology of the drug created a bias towards prepotent involvement of dopamine transmission in addiction, when in fact the learned associations ultimately driving craving and relapse depend more on corticofugal glutamate transmission. Did these approaches bear fruit over 18 years?
The good news is that the brain circuitry involving cortical and allocortical (amygdala and hippocampus) glutamate transmission has become central to our understanding of the long-term changes produced by cocaine, and is now studied using a variety of contingent drug use models that incorporate a withdrawal period. For example, it is generally accepted that the glutamatergic projection from the medial prefrontal cortex to the nucleus accumbens core mediates reinstated drug seeking (Kalivas, 2009; Luscher and Malenka, 2011) . For this reason, many in the field have expended great effort to characterize the neurobiological adaptations produced at this synapse after drug use.
The bad news is that as we have come to measure more subtle adaptations, glutamatergic plasticity has proven to be even more dependent on experimental conditions than we proposed 18 years ago. Thus, beyond simply differences between contingent and noncontingent drug administration, different drugs, durations of contingent drug administration, and varying withdrawal or abstinence conditions seem to produce distinct adaptations in glutamate transmission. Thus, the capacity of our field to identify a coherent role for glutamate that can be used as a rationale for developing drugs to treat addiction continues to be challenged by long-term neuroadaptations in corticofugal glutamate projections that are distinct between different classes of addictive drugs, and between dissimilar dosing and treatment protocols.
Here we briefly assess the status of glutamate transmission in drug addiction. In doing so, we suggest criteria and perspectives on how we might organize the rapidly emerging surfeit of data on changes in glutamatergic circuitry that may underpin drug addiction.
Discerning criteria for identifying relevant cocaine-induced changes in brain
Over the last 10 years, most investigators with a goal of elucidating the neurological basis of relapse to drug use have adopted a substantial withdrawal period (typically weeks). Unfortunately, even by using self-administration paradigms and extended withdrawal, marked differences between some studies remain, especially if different addictive drugs are employed. Here, we suggest new criteria that may help disentangle the literature and assist in distilling the neuroadaptations critical to the uncontrollable motivation to seek drug.
Criterion #1: Can the adaptation be observed after withdrawal from self-administration of different classes of addictive drug? Since the vulnerability to relapse is a shared endophenotype of addiction to all drugs, the underlying biology should contain shared circuits and cellular plasticity. The exemplar of a need for this criterion is the immense amount of work conducted to discern the signaling pathways underpinning the increased spine density produced in the nucleus accumbens after withdrawal from contingent or noncontingent cocaine administration (Russo et al., 2010) . Unfortunately, this morphological adaptation is not produced by opioids (Robinson and Kolb, 2004; Shen et al., 2011) , yet both cocaine and heroin engender an enduring vulnerability to relapse. This is not to say that the knowledge obtained with cocaine does not have great value in understanding mechanisms of synaptic plasticity, just that it seems unlikely that this work will reveal molecular targets for neuropathologies of drug addiction that are shared by psychostimulants and opioids.
Criterion #2: Consider involvement of the entire tetrapartite synapse. The study of neuroadaptations produced by drugs has focused on both pre-and postsynaptic changes in neurotransmission. However, over the last 20 years it has become clear that glia are involved in synaptic plasticity and regulating synaptic transmission. Accordingly, neuroadaptations in the patterned expression of glial proteins, such as glutamate transporters, need to be considered to understand how drugs of abuse may provoke enduring or transient neuroadaptations in glutamate transmission (Bridges et al., 2012; Vijayaraghavan, 2009 ). More recently, involvement of signaling in the extracellular space has come into focus as a fourth component of the synapse where druginduced neuroadaptations may affect glutamate transmission (Smith et al., 2015) . The extracellular space is composed of proteins secreted by neurons and glia and constitutes ~20% of neuropil volume. The proteinaceous extracellular matrix (ECM) serves an important role in intra-and extracellular signaling that is catalyzed by synaptic activation of matrix metalloproteases (MMPs) (Huntley, 2012; Senkov et al., 2014) . Thus, synaptic plasticity arises from coordination amongst all four components of the tetrapartite synapse: presynapse, postsynapse, astroglia and ECM (Figure 1 ).
Criterion #3: Make measurements during a highly motivated drug-seeking event. In addition to training rats to self-administer drug, and measuring enduring changes after a withdrawal period, one can also make important measurements during a highly motivated state of drug seeking. Understanding the neurobiological consequences of the drug-seeking event is critical to understanding the uncontrollable desire elicited when addicts are presented with stimuli associated with the drug experience. Indeed the strong drive to use drug and relapsing to drug use are cardinal endophenotypes shared by addiction to all drug classes. Figure 2 illustrates two popular routes for studying relapse (Venniro et al., 2016) . The first, forced abstinence, is withdrawal from daily drug use in a non-drug environment (usually the home cage), then returning the animals to the drug-paired context to elicit a dramatic drug-seeking response (typically pressing a lever or nose-poking without drug delivery). The second model, extinction, involves pairing drug delivery during self-administration with a discrete cue, such as a light and tone. During withdrawal the drug-seeking response elicited by the drug context is extinguished by daily exposure to the context without drug. Later, restoring drug-associated cue(s) to the extinguished context motivates animals to aggressively seek drug without drug delivery. Using either model it is possible to measure changes in the glutamatergic corticostriatal system that parallel the time-course of the drug-seeking event, and are produced in animals trained to self-administer different drug classes.
Enduring corticostriatal adaptations in glutamate transmission that are shared between classes of addictive drug
The most complete literature on enduring adaptations in corticostriatal glutamate synapses after withdrawal from drug selfadministration has been obtained with cocaine (Dong and Nestler, 2014; Luscher and Malenka, 2011; Wolf, 2010) . Enduring adaptations have been reported in all tetrapartite compartments, including changes that are indicative of synaptic potentiation, such as increased presynaptic release probability, increases in AMPA currents and increases in dendritic spine density and/or head diameter ( et al., 2011). Unfortunately, none of these adaptations are produced after withdrawal from opioid self-administration (Robinson and Kolb, 2004; Shen et al., 2011) , and thus do not meet Criterion #1 listed above.
However, by considering the entire tetrapartite synapse, certain adaptations have been discovered that span across drug classes ( Figure 1 ). In the core subcompartment of the nucleus accumbens (NAcore), astrocytes show reduced glutamate transport via EAAT2 after withdrawal from addictive drugs, including cocaine, nicotine, heroin and alcohol (Mulholland et al., 2016) . In the corticoaccumbens projection there is also reduced mGluR2/3 presynaptic signaling due to a down-regulation of the receptor and/or an increase in the Gi subunit binding protein Activator of G-protein Signaling-3 (AGS-3). Increased AGS-3 reduces mGluR2/3 coupling to Gi by binding to Gi and preventing the reformation of the G-protein heterotrimer. AGS-3 is increased after withdrawal from cocaine, heroin and alcohol, and mGluR2/3 is down-regulated after cocaine or alcohol (Bowers et al., 2004 (Bowers et al., , 2008 Mulholland et al., 2016; Yao et al., 2005) . A final enduring change in corticostriatal synapses that crosses drug classes is a loss in the ability to induce LTP or LTD. An enduring loss of corticostriatal synaptic plasticity has been shown for alcohol, cocaine and heroin (Martin et al., 2006; Marty and Spigelman, 2012; Moussawi et al., 2009; Pascoli et al., 2014; Shen and Kalivas, 2013) .
Transient neuroadaptations during induced drug seeking that are present across drug classes
A typical relapse event consists of two stages: a highly motivated drug-seeking phase, which if successful terminates in a drug-taking phase. Surprisingly, neurobiological changes produced during the relapse event itself are not widely studied. Recently, we have used the animal model in Figure 2 to examine changes associated with drug seeking that are initiated by a drug-associated cue. We have identified a number of transient synaptic alterations that are shared across drug classes and involve the entire tetrapartite synapse. Importantly, these measurements are made during a state of highly motivated drug seeking, but without drug access.
The down-regulation of EAAT2, combined with reduced negative regulation of presynaptic glutamate release probability by mGluR2/3 increases the spillover of synaptic glutamate in the NAcore during reinstated drug seeking in animals extinguished from alcohol, cocaine, heroin, methamphetamine and nicotine self-administration (Mulholland et al., 2016) . Prelimbic cortex projections to the NAcore are critical contributors to the spillover since inhibiting activity in prelimbic cortex prevents spillover. The spillover is transient and triggers activation of MMP-9, which is a necessary mediator of the induction of transient synaptic potentiation (t-SP) in medium spiny neurons (Smith et al., 2014) . Transient-SP has been shown ex vivo using brain slices obtained after initiating reinstatement to measure increases in AMPA glutamate receptor currents and spine head diameter, or in vivo using evoked responses in the NAcore elicited by electrical stimulation of the prelimbic cortex (Famous et al., 2008; Gipson et al., 2013a Gipson et al., , 2013b Shen et al., 2011) . Transient-SP returns to pre-reinstatement baseline by 120 min after initial presentation of the drugassociated cue. Importantly, the extent of t-SP (AMPA/NMDA ratio and spine head diameter) is positively correlated with the intensity of the drug-seeking response (lever pressing) over the first 15 min after initiating cue presentation (Gipson et al., 2013a) .
Potential therapeutic utility of using the three criteria and conclusions
Addiction to all classes of abused drugs shares a defining characteristic of being a chronic, relapsing disorder typified by an overwhelming motivation to use the drug in spite of negative consequences. As a shared endophenotype of all drug addiction, Criterion #1 poses that the most significant neurological adaptations to study in animal models of addiction will be those shared by different drug classes. In studying shared adaptations, Criterion #2 poses the need to consider not just classic synaptic transmission and plasticity, but to include adaptations in astroglia and the extracellular space, which together with the pre-and post-synapse constitute the tetrapartite synapse. Figure 1 outlines four such adaptations measured in the NAcore that are enduring and involve tetrapartite synaptic activity. Directly or indirectly manipulating any four of these adaptations inhibits drug seeking in animal models (Bossert et al., 2006; Bowers et al., 2008; Moussawi et al., 2009; Pascoli et al., 2014) , and two are readily drugable targets, EAAT2 and mGluR2/3. Indeed, trials have been conducted with N-acetylcysteine to restore EAAT2 that show good efficacy at reducing the motivation to seek drug (craving), and more modest efficacy in reducing relapse to drug use (McClure et al., 2014; Rushworth and Megson, 2014) . This profile may help explain why N-acetylcysteine is also modestly effective in treating a variety of psychiatric disorders including major depression, post-traumatic stress disorder, gambling and trichotillomania . Similar to craving in addiction, in all of the disorders where N-acetylcysteine has shown efficacy intrusive thoughts can initiate psychiatric symptoms of the disorder. Self-administration animal models for inducing a drug-free state of highly motivated drug seeking and measuring neuroadaptations. Following self-administration of an addictive drug, animals are placed in an extended withdrawal period, either with extinction training or without (forced abstinence). Both enduring and transient adaptations will be expected if measures are made shortly (0.5-72 hours) after discontinuing self-administration (red arrow). Transient changes may be part of a signaling sequence that establishes enduring changes. Enduring neuroadaptations are measured at the end of an extended (weeks) withdrawal period (red arrows). Highly motivated drug seeking can then be induced by either placing the animal in an un-extinguished, drug-paired context, or within an extinguished context by presenting the animal with drug-conditioned discrete cues, such as a light or tone. To estimate neurological adaptations elicited by entering a highly motivated drug-seeking state, animals are examined at different times after initiating drug seeking with context or cues. Importantly, while the extent of self-administration training and withdrawal period varies, for studying motivated drug seeking these two approaches are the most simple to interpret and widely used.
Finally, following on the logic of Criterion #1 that the motivation to seek drug is a shared endophenotype of all addictive drugs, Criterion #3 is that transient adaptations seen across drug classes during a state of high motivation to seek drug may be possible targets for treating addiction. Figure 1 outlines three shared, transient events produced by presenting a drug-conditioned cue to initiate drug seeking. Of these, the most readily available for drug development in treating addiction is MMP-9. Unfortunately, earlier trials with MMP inhibitors for other disorders have been largely abandoned due to unacceptable side-effects (Vafadari et al., 2015) . Nonetheless, research in addiction adopting Criterion #3 is nascent, and other potentially drugable targets may emerge as new neuroadaptations produced during a relapse event are discovered.
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Introduction
The euphoria produced by cocaine administration in humans is well documented. In the later half of the 19th century, many respected physicians and academicians touted the effects of cocaine to increase clarity of thought and improve general well being. A classic description is provided by Sigmund Freud: '[The effects were] exhilarating and lasting euphoria, which in no way differs from the normal euphoria of a healthy person.... You perceive increase in self-control and possess more vitality and capacity for work.... Absolutely no craving for the further use of cocaine appears after the first, or even repeated, taking of the drug' (Jones, 1953) . Of course, Freud later acknowledged that repeated use of cocaine can produce long-term changes in behavior, including drug craving and the induction of psychopathologies such as paranoia and mania.
There exist large individual differences in the behavioral response to cocaine, with some individuals showing psychopathologies with only one or a few administrations and others being relatively resistant to the induction of paranoia (Satel and Edell, 1991) . However, if we consider that the 'normal' response to an acute administration of cocaine resembles the positive description by Freud, and that at least a subpopulation of individuals develop longterm behavioral changes with chronic use, the overriding question is how does the behavioral effect of cocaine transform from a positive experience into a response that is perceived as negative, and may manifest as craving and psychopathology? The simple answer is that long-term alterations in brain function have been produced by repeated cocaine use.
Discerning criteria for identifying relevant cocaine-induced changes in the brain
Identification of the long-term alterations in brain function by repeated cocaine administration has been a focus of many research efforts over the last two decades (Nestler et al., 1993; White et al., 1995a; Pierce and Kalivas, 1997) . This effort has consistently revealed the induction of many changes in cellular processes. However, the plethora of cocaine-induced changes revealed by the discovery process sometimes appear contradictory, and have proven difficult to integrate into a model of alterations in the nervous system that are specifically associated with the induction of enduring behavioral changes. For example, repeated cocaine administration in rodents has been reported to produce a decrease, an increase or no change in the release of dopamine, dopamine transporter activity or dopamine receptor density in the nucleus accumbens (Robinson and Becker, 1986; Pierce and Kalivas, 1997) . Assuming this conglomerate of seemingly contradictory data is not the result of individual differences in groups of experimental animals, it is necessary to devise discerning criteria to sift through the literature for brain neuroadaptations relevant to the induction of craving and other long-term behavioral alterations.
A primary criterion that has proven useful is that, akin to cocaine-induced behavioral plasticity, any relevant cellular change in the brain should be long lasting. The changes in cocaine-induced behaviors, whether craving or paranoia, are very enduring and may persist for the lifetime of the individual (Sato et al., 1983; O'Brien et al., 1992) . This criterion is very discerning and permits removal from consideration of a host of cocaine-induced changes that persist from only a few hours to a week after discontinuing repeated cocaine administration. For example, when considering the changes in dopamine transmission outlined above, only increased releasability of dopamine and increased dopamine transporter activity are consistently identified for at least 2 weeks after discontinuing repeated cocaine administration. The application of this criterion has proven useful in greatly reducing the number of neuroadaptations considered (Pierce and , and its utility arises in part because some cellular neuroadaptations elicited by repeated cocaine administration are short-term, compensatory changes in brain function. Some alterations can be interpreted as tolerance to the acute effects of cocaine, including the relatively short-term reduction in dopamine autoreceptor function (Ackerman and White, 1992) , as well as diminished release and basal extracellular levels of dopamine (Weiss et al., 1992; Hooks et al., 1994) . However, other neuroadaptations that would seem to support enhanced behavioral responsiveness, such as increased sensitivity of dopamine neurons to excitatory amino acids, also persist for only a few days after discontinuing repeated drug administration (Zhang et al., 1997) . Thus, during the first few days after discontinuing repeated drug administration, the complex profile of neuroadaptations is very difficult to interpret in terms of changes relevant to long-term behavioral alterations.
A second criterion that may be useful for discriminating cellular neuroadaptations that are relevant to the induction of long-term behavioral alterations is the type of animal model employed. The first potentially discerning aspect is that animal models employ two general kinds of drug administration. The majority of studies investigating cocaine-induced cellular neuroadaptations use repeated noncontingent administration of a drug, while fewer studies employ drug self-administration. Unfortunately, cellular information arising from the studies employing contingent drug administration is relatively sparse. However, from the existing literature long-term neuroadaptations are often fairly consistent between the two models (Hooks et al., 1994; White et al., 1995b; however, see Dworkin et al., 1992) . If general agreement in the type of cocaineinduced neuroadaptations between the contingent and noncontingent models proves to be the rule, this is a comfort for the majority of investigators employing the technically facile noncontingent model, but it also removes the utility of this distinction as a discerning criterion for identifying cellular neuroadaptations that are relevant to long-term behavioral alterations.
Rather than considering the form of drug administration, a more important discerning criterion may be the identification of behavioral paradigms that more closely parallel the longterm behavioral alterations produced by repeated cocaine administration in humans. Unfortunately, there exists a relative dearth of cellular information from behavioral models that have been proposed to more closely parallel the behavioral changes in humans. Because of its technical facility, most investigators employ repeated noncontingent administration of cocaine and employ augmented cocaine-induced motor hyperactivity as a behavioral index of enduring neural plasticity. While this has been proposed as a behavioral model of the induction of paranoia by repeated cocaine exposure, it is not a model of craving.
The reinstatement of drug self-administration has become a popular model for attempting to divine the neural mechanisms of craving (Stewart et al., 1984; Shaham and Stewart, 1995; Neisewander et al., 1996; Self et al., 1996) . In this model, the capacity of a stimulus to reinstate or prevent the reinstatement of cocaine self-administration is evaluated. This paradigm is amenable to both pharmacological and anatomical analysis of the neural substrates involved in reinstating cocaine selfadministration. While data are beginning to emerge, there is presently scant cellular information derived from drug reinstatement studies. It may be that such emerging data reveals that the manipulations influencing the reinstatement of cocaine self-administration parallel those which affect the expression of augmented motor behaviors in the sensitization model of repeated cocaine administration (Cornish et al., 1997) . If this is the case, the cellular mechanisms derived from studies on the behavioral sensitization of motor activity will prove useful in understanding the neurobiology of craving and developing rational pharmacotherapy. The remainder of this paper will make this assumption and describe neuroadaptations associated with behavioral sensitization of motor activity. However, where data exists using drug reinstatement paradigms, these findings will be evaluated against the adaptation elicited in the motor sensitization paradigm.
Neuroadaptations potentially associated with cocaine craving
Long-term neuroadaptations to repeated cocaine arise from two overlapping effects of cocaine, (1) a pharmacological action to block monoamine transporters, notably dopamine transport, and (2) an interaction between this pharmacological action and the animal's environment. The former effect will presumably occur in all animals containing the normal complement of monoamine transporters, while the latter neuroadaptations will vary depending upon differences in environmental stimuli. In experimental animals, environmental stimuli have long been recognized to modulate both the expression of sensitization to cocaine-induced motor hyperactivity and reinstatement of drug self-administration (Stewart and Vezina, 1988; Shaham et al., 1997) . Furthermore, craving for the drug in cocaine addicts is readily precipitated by environmental stimuli that were previously associated with drug taking (Childress et al., 1997) .
Pharmacologically induced neuroadaptations
The molecular site of action for the initiation of cocaineinduced changes is on the monoamine transporters (Reith et al., 1986) , notably the dopamine transporter. Long-term alterations in dopamine transmission have been determined in many laboratories. Some contradictions exist between laboratories and there are clearly different long-term effects on dopamine transmission in different brain nuclei. Nonetheless, based upon the fact that dopamine agonists will reinstate cocaine or amphetamine self-administration (de Wit and Stewart, 1981; Neisewander et al., 1996) and that the nucleus accumbens has been identified as a structure critical for drug self-administration (Koob, 1992) , a long-term augmentation in dopamine transmission can be hypothesized to promote drug craving. The long-term changes in dopamine transmission in the brain produced by repeated cocaine administration include long-term alterations in both presynaptic dopamine release and post-synaptic dopamine transduction (Nestler et al., 1993; White et al., 1995a; Pierce and Kalivas, 1997) . The changes measured in the nucleus accumbens are consistent with an amplification of dopamine transmission in animals behaviorally sensitized to repeated cocaine administration and constitute a potentially important substrate for craving. However, Neisewander et al. (1996) demonstrated that the release of dopamine by a cocaine injection to induce reinstatement was less than the equivalent dose given to cocaine naive rats. This is contrary to many reports of increased extracellular dopamine in rats treated with daily noncontingent cocaine injections (for a review, see Pierce and , and potentially constitutes an important divergence between the two animal models. A possible explanation is that Neisewander et al. (1996) examined rats at only 8 days after discontinuing cocaine self-administration. Hooks et al. (1994) found that at 1 day after discontinuing cocaine self-administration, the increase in extracellular dopamine elicited by a noncontingent cocaine injection was blunted compared with yoked saline control subjects, but after 21 days of withdrawal a robust augmentation was observed.
In addition to augmented dopamine transmission in the nucleus accumbens, there is a reduction in cocaineor stressinduced dopamine release in the prefrontal cortex of animals pretreated with daily cocaine (Sorg and Kalivas, 1993; Sorg et al., 1997) . This may also contribute to dopamine-dependent craving because decreased dopamine transmission in the prefrontal cortex is thought to increase excitatory output to mesoaccumbens dopamine neurons (Mitchell and Gratton, 1992; Sorg et al., 1997) . The changes in dopamine transmission that may be important in cocaine craving are illustrated in Fig.  1 (A) .
Environmentally induced neuroadaptations
The influence of environment on the neuroadaptations associated with motor sensitization to cocaine will presumably have an increasing impact the further distal from the dopamine transporter the changes are identified. Most well characterized are the cocaine-like behaviors elicited by environmental stimuli that have been intentionally or unintentionally paired with cocaine administration. While clear mechanistic data is only beginning to emerge, there has been a general focus on alterations in excitatory amino acid (EAA) transmission that can be regulated by environmental stimuli. Three studies have been directly concerned with this: (1) Meil et al. (1997) report that lesions of the amygdala, which has dense EAA projections to the nucleus accumbens and prefrontal cortex, prevents cueinduced reinstatement of cocaine i.v. self-administration; (2) Pierce et al. (1996) demonstrated that the behavioral excitation arising from stimulation of AMPA receptors in the nucleus accumbens is augmented only in a portion of rats that develop behavioral sensitization to repeated systemic cocaine injections ; Bell and Kalivas (1996) followed up this report and demonstrated that the augmentation in behavioral response to AMPA microinjection into the nucleus accumbens occurs only in animals where the test environment has been specifically Figure 1 A model of the long-term changes in mesocorticolimbic circuitry, which may partly mediate the enduring behavioral changes produced by cocaine addiction, such as craving and paranoia. The dashed arrows refer to reduced transmitter release, while the solid arrows mdicate increased release or intracellular signahng. (A) Pharmacologically induced changes in dopamme (DA) transmission There is a reduction m pre-synaptic dopamine transmission in the prefrontal cortex (PFC) (Sorg et al., 1997) and an increase m preand post-synaptic dopamme transmission in the nucleus accumbens. The increased dopamme release is mediated by increased calcium transduction through the calmodulin (CaM) and CaM-kinase II cascade (Pierce and Kahvas, 1997) . The increase m post-synaptic dopamine transmission arises partly from mcreased D, receptor transduction (Nestler et al., 1993; White et al, 1995a) . (B) Changes m excitatory ammo acid (EAA) transmission that are potentially regulated by environmental stimuli. There is an increase in glutamate pre-synaptic transmission m both the ventral tegmental area (VTA) (unpubhshed observations) and nucleus accumbens (Pierce et al., 1996; Reid and Berger, 1996) . There is an increase m post-synaptic glutamate transmission in the nucleus accumbens (Pierce et al., 1996; Bell and Kalivas, 1996; Churchill et al., 1997;  however, see White et al., 1995a ). (C) Overlay of changes in dopamine (pharmacological) and glutamate (environmental) transmission shown in (A) and (B), respectively. All of the proposed changes will likely promote increased motor output because microinjection of dopamine or glutamate agonists mto the nucleus accumbens, glutamate agomst into the ventral tegmental area or dopamine antagomst mto the prefrontal cortex will promote basal or psychostimulant-induced locomotion (for review, see paired with the daily injections of cocaine; and (3) Cornish et al. (1997) found that the reinstatement of cocaine selfadministration could be induced by a microinjection of AMPA into the nucleus accumbens. This indicated that, in animals that had been trained to self-administer cocaine, AMPA receptor stimulation in the nucleus accumbens acts in a similar manner to an environmental or interoceptive stimulus that is signaling the presence of cocaine.
In addition to the three studies described above, which are directly concerned with a role for EAA transmission in environmentally cued behavioral changes elicited by repeated cocaine exposure, there are numerous studies consistent with this idea. For example, in rats pretreated with repeated cocaine, the capacity of a cocaine challenge to elevate extracellular glutamate levels in the nucleus accumbens and ventral tegmental area is enhanced (Pierce et al., 1996; Reid and Berger, 1996) . Interestingly, in the nucleus accumbens, the augmented glutamate transmission only occurs in the subpopulation of rats receiving daily cocaine injections that actually develop significant motor sensitization, whereas animals not demonstrating behavioral sensitization did not show enhanced extracellular glutamate. Similarly, there is an increase in GluRl protein content in the nucleus accumbens of rats that develop behavioral sensitization to cocaine, but not in animals receiving daily cocaine that did not express sensitized motor behavior (Churchill et al., 1997) . Finally, lesions of the dorsal prefrontal cortex, a cortical region supplying EAA input to the nucleus accumbens (Sesack et al., 1989) , prevent both the expression of behavioral sensitization and the majority of the increase in extracellular glutamate produced in the nucleus accumbens in response to a cocaine injection in animals sensitized to daily cocaine (Pierce et al., 1996) . Taken together, these studies indicate that factors that are in addition to drug administration are co-determinants of increasing preand post-synaptic glutamate transmission. Environmental stimuli may be one of these factors, although this remains to be shown for extracellular glutamate content or GluRl protein content, as it was demonstrated for enhanced responsiveness to AMPA microinjection into the nucleus accumbens (Bell and Kalivas, 1997) .
Putting these changes in glutamate transmission together, we can construct the model in Fig. 1 (B) . This model shows an increase in glutamate output from the prefrontal cortex to both the nucleus accumbens and ventral tegmental area, as well as long-term enhanced post-synaptic responsiveness to AMPA receptor stimulation in the nucleus accumbens.
Conclusions
Repeated exposure to cocaine can produce long-term changes in brain neurotransmission. These neuroadaptations arise from a direct pharmacological action of repeated cocaine at the dopamine transporter and from environmental stimuli associated with repeated exposure to cocaine. The pharmacological actions of cocaine are becoming well characterized. 0 However, while the expression of behavioral sensitization by repeated cocaine is dramatically influenced by environmental stimuli, the interplay between cocaine and the environment is only beginning to be understood at a cellular and circuitry level. Furthermore, the role that these neuroadaptations play in cocaine craving is primarily conjecture. Nonetheless, Fig.  I(C) overlays the circuit model of pharmacological sensitization in Fig. I(A) with the proposed model of how environmental stimuli may impact the expression of sensitization illustrated in Fig. 1 (B ). This preliminary model reveals long-term modifications in an interconnected circuit, previously referred to as the motive circuit . The motive circuit is highly integrated with reciprocal and topographically associated interconnections. This anatomical organization highlights the major challenge to understanding the respective roles of pharmacology and environment in drug craving. Because of the highly interactive anatomical relationship between the nuclei comprising this circuit, it is difficult to derive linear cause and effect relationships between drug action, environmental influences and behavior. Thus, a drug/ environment-induced cellular neuroadaptation in one nucleus will produce simultaneous changes in other nuclei within the motive circuit. Understanding this dynamic homeostasis within the motive circuit will constitute an important and necessary stride towards understanding how pharmacological and environmental insults produce enduring pathological changes in behavior, including drug craving and relapse.
